Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. - Wikidata - awgldk - TriplyDB

Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study.

Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study.

http://www.wikidata.org/entity/Q34155432

about

Digitalis for treatment of heart failure in patients in sinus rhythm Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients Digitalis for treatment of heart failure in patients in sinus rhythm Assessing the impact of heart failure specialist services on patient populations Third-generation beta-adrenoceptor antagonists in the treatment of hypertension and heart failure β-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature New advances in beta-blocker therapy in heart failure Heart Failure: a Major Cardiovascular Complication of Diabetes Mellitus Sacubitril/valsartan in heart failure: latest evidence and place in therapy Present and future pharmacotherapeutic agents in heart failure: an evolving paradigm Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases Improved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS-II) trial Management Of Atrial Fibrillation In Patients With Heart Failure Beta-blockers in the treatment of hypertension: new data, new directions.Adverse drug events and associated factors in heart failure therapy among the very elderly Development, optimization and in vitro evaluation of alginate mucoadhesive microspheres of carvedilol for nasal delivery.Multiple interactions between the alpha 2C- and beta1-adrenergic receptors influence heart failure survival.Role of beta-blockers in patients admitted for worsening heart failure in a real world setting: data from the Italian Survey on Acute Heart Failure.Antihypertensive medications: benefits of blood pressure lowering and hazards of metabolic effects.Relation of beta-blocker use with frequency of hospitalization for heart failure in patients with left ventricular diastolic dysfunction (from the Heart and Soul Study)Mean Platelet Volume as a Predictor of Heart Failure-Related Hospitalizations in Stable Heart Failure Outpatients with Sinus Rhythm.Is there a role for carvedilol in the management of pediatric heart failure? A meta analysis and e-mail survey of expert opinion.New pacing technologies for heart failure.Beyond desensitization: physiological relevance of arrestin-dependent signaling.Gene expression and β-adrenergic signaling are altered in hypoplastic left heart syndrome.Ten-year prognosis of heart failure in the community: follow-up data from the Echocardiographic Heart of England Screening (ECHOES) study.β-Adrenergic receptor antagonists ameliorate myocyte T-tubule remodeling following myocardial infarction.Functional selectivity in adrenergic and angiotensin signaling systems.Lack of improvement in outpatient management of congestive heart failure in the United States Total beta-adrenoceptor knockout slows conduction and reduces inducible arrhythmias in the mouse heart.Feasibility of evidence-based diagnosis and management of heart failure in older people in care: a pilot randomised controlled trial Treatment of heart failure with normal ejection fraction Metabolomic distinction and insights into the pathogenesis of human primary dilated cardiomyopathy.β-Blockers for the prevention of sudden cardiac death in heart failure patients: a meta-analysis of randomized controlled trials ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling.Partially silencing brain toll-like receptor 4 prevents in part left ventricular remodeling with sympathoinhibition in rats with myocardial infarction-induced heart failure.GENETIC CAUSES OF DILATED CARDIOMYOPATHY.The causes, consequences, and treatment of left or right heart failure B-CONVINCED: Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode.

P2860

Q24194992-69E89B62-78AC-4EC2-8A5D-476735638D71 Q24241045-E249A080-B8A1-4EF0-9406-52D169EEEFDF Q24247158-9C2D25D8-6E63-4CF2-A74F-77A29282DEAA Q24796348-515A708E-32A6-41B0-BCA3-CC04094560B6 Q26822825-70C5514D-373D-4220-A72A-22D3217471F9 Q26861630-1A8ABF22-708E-43E0-A8EB-6CD7AB2F1169 Q26865919-01D98952-4567-4C5B-8DFF-6B334A29FD96 Q28066310-57E20A0E-3A96-424E-907F-435D95D91456 Q28070191-B2CDFC19-02A5-465A-A310-B5A7201CE572 Q28077186-D508198E-2567-4CCC-ADA2-A6612257CDA0 Q28182631-501D92FE-81B7-4AE7-B3E5-B23D6F561B3E Q28278243-58088D77-3078-4896-A773-34C043C4A321 Q30354835-D73F89CD-5BD3-4EA9-A9F0-1297F08300BE Q31149036-1A016300-F249-41BD-89E7-B9F7CBE7B411 Q33162167-437AA36F-697E-473C-BBE5-C764FE938EE3 Q33377954-F9F5DFCA-D7AB-4307-B00D-28288D35F444 Q33378995-F43D3371-6646-4E7D-885F-8F4C0F94F12D Q33400219-028BF945-C31C-4F2B-B3AF-062F01D9E850 Q33561456-06F65889-B0C2-4B98-A9D9-0FB124B9EE19 Q33682749-741EF5A7-CB78-4229-B9B1-6B6008CF2F56 Q33729860-54B9B56A-AC90-4BC5-8AC1-F3F465E15C0D Q33735757-601EED1A-7438-49AD-8073-790AE16C81EB Q33815045-60116E96-00E0-4105-93EC-A87E2E01D734 Q33890802-27C99A6F-EA15-4C98-A761-BFD4C219C8E2 Q33954281-7E1A6C61-A730-421D-93E7-DF324DABAA83 Q34130091-B0E37763-338B-457D-8B74-5A7068C853A6 Q34178045-1F0BFF84-FF8A-4611-95DB-D8037602A7FD Q34359586-671751FB-A82B-46D5-98B7-5925E2B7C7E7 Q34369676-6D6A2ABB-ACA1-4AD7-B808-262D7938AE3D Q34469952-3D150D3D-55E5-43B5-9021-EB4EDF38C5CE Q34476506-66E3C023-B15B-4032-B115-E2505F87946C Q34477322-AFAE4286-CA76-4924-8E50-BC6229DAE1F9 Q34768148-242F5196-0ED8-4ADA-822E-A5339C329D62 Q34815329-C5CF1A33-F762-4F78-A35B-84A65CD95A7A Q34830023-4FD88A63-4CA9-4B62-AD43-1D1129FF6EFF Q34837191-BBBF3550-0605-4D63-8580-705FD2E7C685 Q34852626-EE7B4369-64D3-425E-A75E-DE3CA8735801 Q34881335-10CF5875-0C99-486A-906B-E5685C7EEADB Q34987168-4610EBD7-7CBC-49B3-BBFA-E88A3EBE0376 Q35000296-658BA710-06BF-4D5D-9F12-EBDB6A20AA7F

P2860

Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study.

http://www.wikidata.org/entity/Q34155432

description

2002 nî lūn-bûn

@nan

2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Effect of carvedilol on the mo ...... e survival (COPERNICUS) study.

@ast

Effect of carvedilol on the mo ...... e survival (COPERNICUS) study.

@en

Effect of carvedilol on the mo ...... randomized cumulative survival

@nl

type

label

Effect of carvedilol on the mo ...... e survival (COPERNICUS) study.

@ast

Effect of carvedilol on the mo ...... e survival (COPERNICUS) study.

@en

Effect of carvedilol on the mo ...... randomized cumulative survival

@nl

prefLabel

Effect of carvedilol on the mo ...... e survival (COPERNICUS) study.

@ast

Effect of carvedilol on the mo ...... e survival (COPERNICUS) study.

@en

Effect of carvedilol on the mo ...... randomized cumulative survival

@nl

P1433

Q34155432-A34919B7-E206-4E4F-A45A-D8A44B6BE805

P1476

Q34155432-09CDF3EC-84DF-4DF7-8ED8-88FFF79205A2

P2093

Q34155432-1FE816E5-187C-4C5F-A5C6-924D16C66640

Q34155432-466AEC2D-E927-4060-9792-53CFB65A5165

Q34155432-48D63EAC-4AA7-4280-9FA9-328D30A6AC26

Q34155432-51F1A993-1529-4C99-B102-19292CC42F26

Q34155432-5984CFA0-4E8B-49AF-B8C5-9A24A5AC23B3

Q34155432-772F2A63-A46B-45B8-B0B7-208103A0BF68

Q34155432-81225918-9D86-430E-95BF-38A4A0E77809

Q34155432-966FD8AE-68E7-4143-A471-9F61BF1FE3CA

Q34155432-AAE7ACE4-9FD5-407B-84D9-E1C49F9DFF26

Q34155432-DD6B7140-99E1-4F0A-8219-2464247495E8

P304

Q34155432-6E476BA2-83AD-4E07-935C-28B249392AA9

P31

Q34155432-6FE47B38-A189-4367-8ADD-7A3E22DA5FDF

P356

Q34155432-BAF8F681-3516-44D7-9F7C-C30DA27E62CB

P407

Q34155432-FA086911-F21E-439A-BFF6-A547D935C2D9

P433

Q34155432-10CCC51B-587A-4E36-92A3-D5135A0017CE

P478

Q34155432-C5954E6F-30DA-44A1-A5A3-16A7BEC12FA3

P50

Q34155432-207CC127-ECBE-48B4-9795-B9D12FE491F4

Q34155432-3FE8C93B-1F9A-41B0-9E0C-0D523F989CF6

P577

Q34155432-07B2C4C8-5AC2-41B0-9CB6-B33A4F0F37DF

P5875

Q34155432-7920BCFE-868F-488C-8D01-78D2D261476B

P698

Q34155432-7EB2F516-00AB-4E46-9970-1134183FFA70

P921

Q34155432-0A6D58C1-4223-4988-88BC-034DBC6F0740

Q34155432-1459C7E6-3DD3-449F-8356-90D59C2624BF

P356

01.CIR.0000035653.72855.BF

P1433

P1476

Effect of carvedilol on the mo ...... e survival (COPERNICUS) study.

@en

P2093

Andrew J S Coats

http://www.w3.org/2001/XMLSchema#string

Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group

http://www.w3.org/2001/XMLSchema#string

Christoph Staiger

http://www.w3.org/2001/XMLSchema#string

David L DeMets

http://www.w3.org/2001/XMLSchema#string

Ellen B Roecker

http://www.w3.org/2001/XMLSchema#string

Hugo A Katus

http://www.w3.org/2001/XMLSchema#string

Ildiko Amann-Zalan

http://www.w3.org/2001/XMLSchema#string

Jean L Rouleau

http://www.w3.org/2001/XMLSchema#string

Michael B Fowler

http://www.w3.org/2001/XMLSchema#string

Milton Packer

http://www.w3.org/2001/XMLSchema#string

P304

2194-2199

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.CIR.0000035653.72855.BF

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P50

Michał Tendera

P577

2002-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11071371

http://www.w3.org/2001/XMLSchema#string

P698

12390947

http://www.w3.org/2001/XMLSchema#string

P921